secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2025-04-07T23:59:59+00:00
Accession:  0001708599-25-000033
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Serina Therapeutics CEO to present at Jones Healthcare and Technology Innovation Conference on April 9
--------------------------------------------------------------------------------

- CEO Steve Ledger will present at the conference in Las Vegas, NV on April 9, 2025 at 3:00 p.m. PDT.
- A live webcast will be accessible via wsw.com; replay available for 90 days.
- Presentation materials include POZ Platform overview covering small molecules, RNA, and ADCs.
- No financial results or material operational updates were disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000170859925000033/0001708599-25-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000170859925000033/ser-20250407.htm
  HTML page:      https://secwatch.observer/filing/0001708599-25-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer